REFERENCES
- United States Renal Data System. Annual Data Report. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive Diseases; 2002.
- Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7(4):523–535.
- Smits JH, van der Linden J, Blankestijn PJ, . Coagulation and hemodialysis access thrombosis. Nephrol Dial Transplant. 2000;15(11):1755–1760.
- Chen F, Jian Z, Xie Q, . Polymorphism of human platelet alloantigen in Chinese patients with acute myocardial infarction and acute ischemic stroke. Chin Med J. 2000;113(8):702–705.
- Beer JH, Pederiva S, Pontiggia L. Genetics of platelet receptor single-nucleotide polymorphisms: Clinical implications in thrombosis. Ann Med. 2000;32(Suppl. 1):10–14.
- Lyman S, Aster RH, Visentin GP, . Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system. Blood. 1990;75(12):2343–2348.
- O’Donnell CJ, Larson MG, Feng D, . Genetic and environmental contributions to platelet aggregation. The Framingham Heart Study. Circulation. 2001;103(25):3051–3056.
- Lyou JY, Chen YJ, Hu HY, . PCR with sequence specific primer-based simultaneous genotyping of human platelet antigen-1 to -13w. Transfusion. 2002;42(8):1089–1095.
- Ifudu O, Macey LJ, Homel P, . Determinants of type of initial hemodialysis vascular access. Am J Nephrol. 1997;17(5):425–427.
- Miller PE, Tolwani A, Luscy CP, . Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int. 1999;56(1):275–280.
- Schwab SJ, Harrington JT, Singh A, . Vascular access for hemodialysis. Kidney Int. 1999;55(5):2078–2090.
- Rios DR, Carvalho MG, Lwaleed BA, . Hemostatic changes in patients with end stage renal disease undergoing hemodialysis. Clin Chim Acta. 2010;411(3–4):135–139.
- Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb–IIIa on nonactivated platelets. J Biol Chem. 1991;266(17):11227–11233.
- Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995;332(23):1553–1559.
- Reiner AP, Schwartz SM, Kumar PN, . Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women. Br J Hematol. 2001;112(3):632–636.
- Lekakis J, Bisti S, Tsougos E, . Platelet glycoprotein IIb HPA-3 polymorphism and acute coronary syndromes. Int J Cardiol. 2008;127(1):46–50.
- Bottiger C, Kastrati A, Koch W, . HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Hemost. 2000;83(4):559–562.
- Bottiger C, Kastrati A, Koch W, . Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement. Am J Cardiol. 1999;84(9):987–991.
- Gorgi Y, Sfar I, Ben Aabdallah T, . Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients. Hemodial Int. 2008;12(3):331–335.